Send me a link:

*Text messaging rates may apply.

 Dow Down 0.05% Nasdaq Up 0.51%

Acorda Therapeutics, Inc. (ACOR)

-NasdaqGS
29.72 Up 0.27(0.92%) 10:36AM EDT - Nasdaq Real Time Price
Prev Close:29.45
Open:29.78
Bid:29.74 x 100
Ask:29.79 x 200
1y Target Est:39.21
Beta:1.78
Next Earnings Date:31-Jul-14ACOR Earnings announcement
Day's Range:29.58 - 30.31
52wk Range:27.51 - 39.95
Volume:45,051
Avg Vol (3m):605,422
Market Cap:1.22B
P/E (ttm):68.64
EPS (ttm):0.43
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ACORUp 0.92%1.22B
BIIBUp 1.24%81.70B
TEVAUp 1.10%46.72B

Key Statistics

Forward P/E (1 yr):39.69
P/S (ttm):3.50
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.40
Quarterly EPS Est (Jun-14) :0.15
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):4.57

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Acorda Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and commercializes novel therapies for multiple sclerosis (MS), spinal cord injury (SCI), and other disorders of the nervous system in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback